Know Cancer

or
forgot password
  • cancer clinical trials in helena, MT

  • Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
    St. Peter's Hospital
    Helena, Montana 59601
    Brain and Central Nervous System Tumors
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    Saint Peter's Community Hospital
    Helena, Montana 59601
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Pregabalin in Treating Women With Hot Flashes
    St. Peter's Hospital
    Helena, Montana 59601
    Breast Cancer, Hot Flashes
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Saint Peter's Community Hospital
    Helena, Montana 59601
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
    St. Peter's Hospital
    Helena, Montana 59601
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    St. Peter's Hospital
    Helena, Montana 59601
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    St. Peter's Hospital
    Helena, Montana 59601
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    St. Peter's Hospital
    Helena, Montana 59601
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Saint Peter's Community Hospital
    Helena, Montana 59601
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
    St. Peter's Hospital
    Helena, Montana 59601
    Breast Cancer